China NMPA Inspection - Jilin Changzhenyuan Biotechnology Co., Ltd. - September 13, 2021
China NMPA unannounced inspection for Jilin Changzhenyuan Biotechnology Co., Ltd. published September 13, 2021. The Jilin Provincial Drug Administration, a regional body under China's National Medical Products Administration (NMPA), issued an announcement on Sep
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA unannounced inspection for Jilin Changzhenyuan Biotechnology Co., Ltd. published September 13, 2021. The Jilin Provincial Drug Administration, a regional body under China's National Medical Products Administration (NMPA), issued an announcement on Sep
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
Unknown Date
Product Type
cosmetics
ID: 5d8b66e5-f1c1-4486-8fdc-0941fc15b3ed
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox